Printer Friendly

Browse Protease inhibitors topic

Articles

1-300 out of 348 article(s) nextnext page
Title Author Type Date Words
Todos Medical says new data from Tollovid study shows its ability to inhibit the 3CL protease, a key element of coronavirus replication. Nov 21, 2020 361
Todos trademarks Tollovid for dietary supplement NLC-001 and strikes distribution deal with The Alchemists Kitchen. Oct 30, 2020 559
Covistat Starts Phase 1 Study of Novel COVID-19 Treatment. Sep 28, 2020 440
Todos Medical gains exclusive rights to distribute dietary supplement NLC-001 under partnership with NLC Pharma. Sep 18, 2020 597
Hepion Pharmaceuticals reports 'positive activity' of CRV431 against SARS-CoV-2. Sep 17, 2020 182
Effect of Low Positive End of Treatment Viral Load with Direct-Acting Antiviral Therapy on Sustained Virologic Response. Pal, Vabhave; Ancha, Nirupama; Mann, Jena; Modi, Apurva A. Aug 31, 2020 2126
Quadruple Therapy Offers High SVR Rates in Patients with HCV Genotype 4 with Previous Treatment Failure. Abo-amer, Yousry Esam-Eldin; Badawi, Rehab; El-Abgeegy, Mohamed; Elsergany, Heba Fadl; Mohamed, Ahme Clinical report Aug 31, 2020 4529
The Impact of Modern Therapeutic Methods on the Oxidant-Antioxidant Equilibrium and Activities of Selected Lysosomal Enzymes and Serine Protease Inhibitor in Amateur Athletes. Sielski, Lukasz; Sutkowy, Pawel; Pawlak-Osinska, Katarzyna; Wozniak, Alina; Skopowska, Agnieszka; Wo Aug 31, 2020 6957
Cocrystal announces publication of data on coronavirus antiviral compounds. Aug 4, 2020 225
Pfizer Shares Covid-19 Research Programme Data Updates. Jul 23, 2020 219
Virtual Screening of Natural Metabolites and Antiviral Drugs with Potential Inhibitory Activity against 3CL-PRO and PL-PRO. Contreras-Puentes, Neyder; Alviz-Amador, Antistio Report Jun 1, 2020 3732
Can family physicians have a role in eradication of hepatitis c infection? Sahin, Ahmet Riza; Erdogan, Aysegul; Gisi, Kadir; Ispiroglu, Murat; Ates, Selma; Okyay, Ramazan Azim May 1, 2020 4551
The impact of direct-acting antiviral treatment on lipid metabolism and insulin resistance in chronic hepatitis C patients: temporary? permanent? Ozdogan, Osman; Yaras, Serkan; Ates, Fehmi; Ucbilek, Enver; Sezgin, Orhan; Altintas, Engin May 1, 2020 6351
Can family physicians have a role in eradication of hepatitis c infection? Sahin, Ahmet Riza; Erdogan, Aysegul; Gisi, Kadir; Ispiroglu, Murat; Ates, Selma; Okyay, Ramazan Azim May 1, 2020 4486
The impact of direct-acting antiviral treatment on lipid metabolism and insulin resistance in chronic hepatitis C patients: temporary? permanent? Ozdogan, Osman; Yaras, Serkan; Ates, Fehmi; Ucbilek, Enver; Sezgin, Orhan; Altintas, Engin May 1, 2020 7135
HIV-1 Drug Resistance, Distribution of Subtypes, and Drug Resistance-Associated Mutations in Virologic Failure Individuals in Chengdu, Southwest China, 2014-2016. Chen, Jiayi; Liu, Yang; Liu, Sijing; Yuan, Dan; Su, Ling; Ye, Li; Gong, Fanghong; Gao, Yushuang; Bal Apr 30, 2020 5768
Cardiovascular Manifestations of HIV Infection--A Review. Nath, Kshitiz; Singh, Lakhan Apr 6, 2020 4672
Real-world efficacy, safety, and clinical outcomes of ombitasvir/paritaprevir/ritonavir [+ or -] dasabuvir [+ or -] ribavirin combination therapy in patients with hepatitis C virus genotype 1 or 4 infection: The Turkey experience experience. Aygen, Bilgehan; Demirturk, Nese; Yildiz, Orhan; Celen, Mustafa Kemal; Celik, Ilhami; Barut, Sener; Apr 1, 2020 9000
Real-world efficacy, safety, and clinical outcomes of ombitasvir/paritaprevir/ritonavir [+ or -] dasabuvir [+ or -] ribavirin combination therapy in patients with hepatitis C virus genotype 1 or 4 infection: The Turkey experience experience. Aygen, Bilgehan; Demirturk, Nese; Yildiz, Orhan; Celen, Mustafa Kemal; Celik, Ilhami; Barut, Sener; Apr 1, 2020 9665
CVS Health's PBM says working to protect supply of medicines useful for COVID-19. Mar 25, 2020 239
High Serum Level of IL-17 in Patients with Chronic Obstructive Pulmonary Disease and the Alpha-1 Antitrypsin PiZ Allele. Pervakova, Margarita Y.; Mazing, Alexandra V.; Lapin, Sergey V.; Tkachenko, Olga Y.; Budkova, Anna I Mar 1, 2020 3839
Silencing of ELK3 Induces S-M Phase Arrest and Apoptosis and Upregulates SERPINE1 Expression Reducing Migration in Prostate Cancer Cells. Mao, Yuanshen; Li, Wenfeng; Hua, Bao; Gu, Xin; Pan, Weixin; Chen, Qi; Xu, Bin; Wang, Zhong; Lu, Chao Mar 1, 2020 5405
Significant decrease in liver stiffness detected by two dimensional shear-wave elastography after treatment with direct-acting antiviral agents in patients with chronic Hepatitis C. Yaras, Serkan; Sezgin, Orhan; Ucbilek, Enver; Ozdogan, Osman; Altintas, Engin Feb 1, 2020 3434
Treatment of HCV infection with direct-acting antiviral agents. Real life experiences from the Euro-Asian region. Ormeci, Necati; Gulsen, Murat Taner; Sezgin, Orhan; Aghayeva, Sevda; Demir, Mehmet; Koksal, Iftihar; Feb 1, 2020 5370
Significant decrease in liver stiffness detected by two dimensional shear-wave elastography after treatment with direct-acting antiviral agents in patients with chronic Hepatitis C. Yaras, Serkan; Sezgin, Orhan; Ucbilek, Enver; Ozdogan, Osman; Altintas, Engin Feb 1, 2020 3483
Treatment of HCV infection with direct-acting antiviral agents. Real life experiences from the Euro-Asian region. Ormeci, Necati; Gulsen, Murat Taner; Sezgin, Orhan; Aghayeva, Sevda; Demir, Mehmet; Koksal, Iftihar; Feb 1, 2020 5308
Impact of Treatment with Direct Acting Antiviral Drugs on Glycemic Control in Patients with Hepatitis C and Diabetes Mellitus. Mada, Pradeep Kumar; Malus, Matthew E.; Parvathaneni, Arvin; Chen, Bing; Castano, Gabriel; Adley, Sh Jan 1, 2020 4273
Tazarotene-Induced Gene 1 (TIG1) Interacts with Serine Protease Inhibitor Kazal-Type 2 (SPINK2) to Inhibit Cellular Invasion of Testicular Carcinoma Cells. Shyu, Rong-Yaun; Wang, Chun-Hua; Wu, Chang-Chieh; Wang, Lu-Kai; Chen, Mao-Liang; Kuo, Chan-Yen; Lee, Dec 31, 2019 5510
CHARACTERIZATION AND PROFILING OF SEED STORAGE PROTEINS OF SOME UNDERUTILIZED BEANS VARIETIES USING SDS-PAGE. K. O. Soetan and D. A. Animasaun Dec 31, 2019 4678
KalVista Shares Sink On Failed Mid-Stage Study Of Diabetic Macular Edema Drug. Shanthi Rexaline Dec 9, 2019 446
Treatment Failure with Direct Antiviral Agents in Patients with Hepatitis C Virus Genotype 1 Infection at the Veteran Affairs Caribbean Healthcare System in San Juan, Puerto Rico. Toro, Doris H.; Figueroa-Rivera, Ivonne M. Dec 1, 2019 1823
Descriptive analysis of World Health Organization-recommended second-line antiretroviral treatment: A retrospective cohort data analysis. Gumede, S.B.; Fischer, A.; Venter, W.D.F.; Lalla-Edward, S.T. Dec 1, 2019 7255
Systematic Review with Meta-Analysis: Efficacy and Safety of Direct-Acting Antivirals for Chronic Hepatitis C Genotypes 5 and 6. Due, Ong The; Chaikledkaew, Usa; Genuino, Anne Julienne M.; Sobhonslidsuk, Abhasnee; Thakkinstian, A Nov 30, 2019 9286
Anti-Viral Drugs Market Size, Emerging Technologies, Future Trends, Competitive Analysis and Segments Poised for Strong Growth in Future 2022. Oct 8, 2019 747
TSG6 Antibody Market Expected to Witness a Sustainable Growth over 2019-2026. Sep 10, 2019 837
TSG6 Antibody Market Expected to Witness a Sustainable Growth over 2019-2026. Sep 9, 2019 852
Evaluation of depression, anxiety and quality of life in hepatitis C patients who treated with direct acting antiviral agents. Kesen, Oguzhan; Kani, Haluk Tarik; Yanartas, Omer; Aykut, Umut Emre; Gok, Bedin; Gunduz, Feyza; Yilm Sep 1, 2019 4258
Evaluation of depression, anxiety and quality of life in hepatitis C patients who treated with direct acting antiviral agents. Kesen, Oguzhan; Kani, Haluk Tarik; Yanartas, Omer; Aykut, Umut Emre; Gok, Bedin; Gunduz, Feyza; Yilm Sep 1, 2019 4449
FDA issues safety communication on certain hepatitis C medications. Aug 28, 2019 151
COVERING THE COVER. Kani, Haluk Tarik Aug 1, 2019 1793
Paritaprevir, ritonavir, ombitasvir, and dasabuvir treatment in renal transplant patients with hepatitis C virus infection. Danis, Nilay; Toz, Huseyin; Unal, Nalan; Yilmaz, Mumtaz; Turan, Ilker; Gunsar, Fulya; Karasu, Zeki; Aug 1, 2019 4280
Paritaprevir, ritonavir, ombitasvir, and dasabuvir treatment in renal transplant patients with hepatitis C virus infection. Danig, Nilay; Toz, Huseyin; Onal, Nalan; Yilmaz, Mumtaz; Turan, Ilker; Gungar, Fulya; Karasu, Zeki; Aug 1, 2019 4401
Characterisation of protease resistance mutations in a South African paediatric cohort with virological failure, 2011-2017. Makatini, Z.; Mda, S.; Towobola, O.; Mthiyane, H.; Miles, P.; Blackard, J.T. Jul 1, 2019 4372
Hepatitis B Virus X Protein-Induced Serine Protease Inhibitor Kazal Type 1 Is Associated with the Progression of HBV-Related Diseases. Zhu, Chengliang; Han, Huan; Li, Jie; Xu, Limin; Liu, Fang; Wu, Kailang; Liu, Xinghui Jun 30, 2019 4133
Eradication of HCV Infection with the Direct-Acting Antiviral Therapy in Renal Allograft Recipients. Armando, Calogero; Evangelista, Sagnelli; Massimiliano, Creta; Silvia, Angeletti; Gaia, Peluso; Paol May 31, 2019 7072
Cocrystal Pharma commences patient enrollment for Phase 2a CC-31244 study. May 20, 2019 152
Alpha 1 Antitrypsin Deficiency Treatment Market key Insights Based On Product Type, End-use and Regi. May 17, 2019 1192
DETECTION OF ALPHA-1 ANTITRYPSIN GENE MUTATIONS BY POLYMERASE CHAIN REACTION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE/DETEKCIJA MUTACIJA GENA ZA [ALFA.sub.1]-ANTITRIPSIN PRIMENOM LANCANE REAKCIJE POLIMERAZE KOD PACIJENATA SA HRONICNOM OPSTRUKTIVNOM BOLESTI PLUCA. Maletic, Jelena Stojcevic; Baculov, Katarina; Sekerus, Vanesa; Vucinic, Natasa; Milanovic, Borko; Ba May 1, 2019 4267
Risk factors for cardiovascular disease in HIV/AIDS patients treated with highly active antiretroviral therapy (HAART) in the central-southern region of the state of Parana-Brazil/Fatores de risco para doenca cardiovascular em pacientes com HIV/AIDS tratados com terapia antirretroviral altamente ativa (HAART) na regiao centro-sul do estado do Parana-Brasil. Muller, Erildo Vicente; Gimeno, Suely Godoy Agostinho May 1, 2019 7511
Prevalence of Nephrotoxicity in HIV Patients Treated with Tenofovir Disoproxil Fumarate: A Single-center Observational Study. Hassan, Kowthar Salman; Balkhair, Abdullah Report May 1, 2019 4529
Dynamic Expression Pattern of SERPINA1 Gene from Duck (Anas platyrhynchos). Gu, Tiantian; Wu, Ningzhao; Zhang, Yang; Huang, Yu; Du, Jinping; Lu, Lizhi; XinshengWu; QiXu; Chen, Apr 30, 2019 4422
Real-life results of treatment with ombitasvir, paritaprevir, dasabuvir, and ritonavir combination in patients with chronic renal failure infected with HCV in Turkey. Yaras, Serkan; Ucbilek, Enver; Ozdogan, Osman; Ates, Fehmi; Altintas, Engin; Sezgin, Orhan Clinical report Apr 1, 2019 2939
COVERING THE COVER. Adali, Gupse Report Apr 1, 2019 1267
Real-life results of treatment with ombitasvir, paritaprevir, dasabuvir, and ritonavir combination in patients with chronic renal failure infected with HCV in Turkey. Yaras, Serkan; Ucbilek, Enver; Ozdogan, Osman; Ates, Fehmi; Altintas, Engin; Sezgin, Orhan Report Apr 1, 2019 2946
Comparison of Antiretroviral Therapy Regimens With Regard to Virological and Immunological Response in Treatment-Naive HIV/AIDS Patients/Tedavi Naif HIV/AIDS Hastalarinda Kullanilan Antiretroviral Tedavi Rejimlerinin Virolojik ve Immunolojik Yanit Acisindan Karsilastirilmasi. Akkaya-Isik, Sinem; Gunduz, Alper; Oncul, Ahsen; Hamidi, Aziz Ahmad; Yildiz-Sevgi, Dilek; Kes-Uzun, Report Apr 1, 2019 4233
Identification and Mapping of a 2,009-bp DNA Deletion in SERPING1 of a Hereditary Angioedema Patient. Wong, Wai-Yu; Wong, Helen; Au, Elaine; Chan, Eric Mar 31, 2019 4042
Corrigendum to "Pioglitazone Attenuates Drug-Eluting Stent-Induced Proinflammatory State in Patients by Blocking Ubiquitination of PPAR". Wang, Zhongxia; Zhang, Tao; Sun, Lizhe; Li, Ruifeng; Wei, Yuanyuan; Fan, Xiaojuan; Yuan, Zuyi; Liu, Correction notice Mar 31, 2019 732
TSG6 Antibody Market to Reap Excessive Revenues by 2026. Mar 21, 2019 1118
Alpha 1 Antitrypsin Deficiency Treatment Market Assessment and Key Insights Analysed till 2025. Mar 20, 2019 998
Tackling Pseudomonas aeruginosa Virulence by a Hydroxamic Acid-Based LasB Inhibitor. Kany, Andreas M.; Sikandar, Asfandyar; Yahiaoui, Samir; Haupenthal, Jorg; Walter, Isabell; Empting, Mar 20, 2019 189
Current Antiretroviral Therapies and Future Trends in Management of Human Immunodeficiency Virus-1 Infection. Bulteel, Naomi S.; Leen, Clifford Report Mar 1, 2019 6001
TSG6 Antibody Market size and Key Trends in terms of volume and value 2018-2026. Feb 26, 2019 860
Characterization of Monoclonal and Polyclonal Antibodies Recognizing Prostate Specific Antigen: Implication for Design of a Sandwich ELISA. Mohseni, Sahar Raoofi; Golsaz-Shirazi, Forough; Hosseini, Mostafa; Khoshnoodi, Jalal; Bahadori, Tann Report Jan 1, 2019 4469
Efficacy and Safety of the Paritaprevir/Ritonavir/Ombitasvir/Dasabuvir Regimen for Chronic Hepatitis C in Hemodialysis Patients/Hemodiyaliz/Hastalarindaki Hepatit C Tedavisinde Paritaprevir/Ritonavir/Ombitasvir ve Dasabuvir Rejiminin Etkinlik ve Guvenligi. Tosun, Guven Gurkan; Sultanova, Fidan; Nihan, A.K.; Hizel, Kenan Jan 1, 2019 4157
Perspective on Prostate Cancer Screening. Carlsson, Sigrid V.; Lilja, Hans Jan 1, 2019 2924
Potato extract may substitute for egg white as protease inhibitor in Pacific whiting. Sep 1, 2018 392
Upregulated Expression of Secretory Leukocyte Protease Inhibitor in Lung by Inhalation of High Concentration of Sulfur Dioxide. Liu, Lei; Ma, Zhuang; Sun, Wen-Wu; Cao, Jian-Ping Letter to the editor Aug 20, 2018 2113
Protease Inhibitors May Worsen Outcomes for HIV + Heart Failure; Higher rates seen for hyperlipidemia, diabetes, coronary artery disease, cardiovascular mortality. Aug 1, 2018 231
Johnson & Johnson announces data for Symtuza for treatment of HIV-1. Jul 24, 2018 295
Medivir reports on conversion of shares. May 1, 2018 139
Medivir reports on conversion of shares. May 1, 2018 135
Gilead presents phase 3 study for women using Biktarvy. Mar 5, 2018 206
A 6-Month-Old Boy with Reddish, Scaly Skin: Netherton Syndrome. Bulut, Fatma Derya; Kor, Deniz; Yilmaz, Berna Seker; Yilmaz, Mustafa; Altintas, Derya Ufuk; Ceylaner Clinical report Mar 1, 2018 1493
KalVista Pharmaceuticals Begins Clinical Trials for Potential Diabetic Macular Edema and Hereditary Angioedema Treatments. Jan 9, 2018 334
Antiretroviral Tedavi Yan Etkilerinin Degerlendirilmesi/The Evaluation of the Side Effects of AntiretroviralTreatment. Basgonul, Sedef; Gencer, Serap; Ozer, Serdar Report Jan 1, 2018 5389
Comparison of Three Different Anti-retroviral Regimens in Terms of Immunological and Virological Response/Uc Farkli Anti-retroviral Tedavi Rejiminin Immunolojik ve Virolojik Acidan Karsilastirilmasi. Sonmez, Ufuk; Atalay, Sabri; Albayrak, Hazal; Turken, Melda; Kose, Sukran Report Jan 1, 2018 3670
Noninvasive Monitoring of Liver Disease Regression after Hepatitis C Eradication Using Gadoxetic Acid-Enhanced MRI. Haider, Lukas; Mandorfer, Mattias; Gungoren, Zeynep; Reiberger, Thomas; Bastati, Nina; Hodge, Jacque Jan 1, 2018 5153
Glucose Metabolism Changes in Patients with Chronic Hepatitis C Treated with Direct Acting Antivirals. Drazilova, Sylvia; Janicko, Martin; Skladany, Lubomir; Kristian, Pavol; Oltman, Marian; Szantova, Ma Clinical report Jan 1, 2018 7883
The Oxidant-Antioxidant Equilibrium and Inflammatory Process Indicators after an Exercise Test on the AlterG Antigravity Treadmill in Young Amateur Female Athletes. Sielski, Lukasz; Sutkowy, Pawel; Skopowska, Agnieszka; Pawlak-Osinska, Katarzyna; Augustynska, Zofia Jan 1, 2018 6413
Systemic Inflammation Characterizes Lack of Metabolic Health in Nonobese HIV-Infected Men. Monczor, Ana N.; Li, Xiuhong; Palella, Frank J., Jr.; Erlandson, Kristine M.; Wiley, Dorothy; Kingsl Jan 1, 2018 7865
Preventing Soft Texture Fish Fillets through Brine Injection Technology. Harikedua, Silvana Dinaintang; DeWitt, Christina A. Mireles Jan 1, 2018 5158
Modelling Optimal Control of In-Host HIV Dynamics Using Different Control Strategies. Ngina, Purity; Mbogo, Rachel Waema; Luboobi, Livingstone S. Jan 1, 2018 7845
Prevalence, Risk Factors, and Pathophysiology of Dysglycemia among People Living with HIV in Sub-Saharan Africa. Njuguna, Benson; Kiplagat, Jepchirchir; Bloomfield, Gerald S.; Pastakia, Sonak D.; Vedanthan, Rajesh Jan 1, 2018 8766
Lamivudine monotherapy in children and adolescents: The devil is in the detail. Fairlie, L.; Bernheimer, J.; Sipambo, N.; Fick, C.; Kuhn, L. Report Dec 1, 2017 3195
Long-term virologic and immunologic responses on darunavir/ritonavir--containing regimens among highly antiretroviral therapy-experienced patients: 7-year follow-up of a prospective cohort study in Sao Paulo, Brazil. Vidal, Jose E.; Santos, Ariane M.R. Dos; de Miranda, Erique J.F. Peixoto; Segurado, Aluisio C. Report Nov 1, 2017 643
2-Drug regimens in HIV treatment: pharmacological considerations. Back, David Editorial Sep 1, 2017 955
Fuentes Named EVP, Research at Blade Therapeutics. Aug 24, 2017 354
AbbVie's hepatitis C treatment to be included in UK's EAMS. May 11, 2017 250
AbbVie's hepatitis C treatment to be included in UK's EAMS. May 11, 2017 246
Lipid impact on HIV heart disease, and antiretroviral impact on lipids. Mascolini, Mark Report Mar 22, 2017 4718
Screening for and managing dyslipidemia in people with HIV. Mascolini, Mark Report Mar 22, 2017 7001
Antiangiogenic VEGF165b Expression in Human Breast MCF7 and MCF-10A Cells Exposed to Reverse Transcriptase and Protease Inhibitors/Expresion de VEGF165b Antiangiogenico en Celulas MCF-7 y MCF-10A de Mama Humana Expuesto a Inhibidores de la Transcriptasa Inversa y la Proteasa. Anthony, Adefolaju Gbenga; Elizabeth, Scholtz Kathrine; Jill, Hosie Margot Mar 1, 2017 5677
Watch for skin reactions from new cancer, hepatitis C drugs. Splete, Heidi Feb 15, 2017 367
US FDA Grants Priority Review to AbbVie's Investigational HCV Regimen. Feb 3, 2017 349
DETERMINACAO DA ATIVIDADE INIBITORIA DE ENZIMAS DIGESTIVAS EM SUPLEMENTOS VENDIDOS NO COMERCIO INTERNACIONAL A BASE DE PROTEINA VEGETAL/Determination of digestive enzymes inhibition activity in vegetable protein based supplements available in international commerce. de Assis, Leonardo Oliveira; de Moura Andrade, Hygor Bruno; de Carvalho, Fabiana Maria Coimbra; Serq Jan 15, 2017 4009
Incidence and Predictors of Antiretroviral Treatment Modification in HIV-infected Adults: A Brazilian Historical Cohort from 2001 to 2010. Braga, Leticia Penna; Mendicino, Cassia Cristina Pinto; Reis, Edna Afonso; Carmo, Ricardo Andrade; d Report Jan 1, 2017 6163
Targets of Neutrophil Influx and Weaponry: Therapeutic Opportunities for Chronic Obstructive Airway Disease. Mardh, Carina Karrman; Root, James; Uddin, Mohib; Stenvall, Kristina; Malmgren, Anna; Karabelas, Kos Jan 1, 2017 10023
Elevated Concentrations of SERPINE2/Protease Nexin-1 and Secretory Leukocyte Protease Inhibitor in the Serum of Patients with Papillary Thyroid Cancer. Stepien, Tomasz; Brozyna, Mateusz; Kuzdak, Krzysztof; Motylewska, Ewelina; Komorowski, Jan; Stepien, Report Jan 1, 2017 2956
Concentration and Separation of Active Proteins from Potato Industry Waste Based on Low-Temperature Evaporation and Ethanol Precipitation. Taskila, Sanna; Ahokas, Mikko; Jarvinen, Juho; Toivanen, Juho; Tanskanen, Juha P. Report Jan 1, 2017 3626
Role of Kallistatin Treatment in Aging and Cancer by Modulating miR-34a and miR-21 Expression. Chao, Julie; Guo, Youming; Li, Pengfei; Chao, Lee Report Jan 1, 2017 5200
Characterization and Identification of Cryptic Biopeptides in Carya illinoinensis (Wangenh K. Koch) Storage Proteins. Mares-Mares, Everardo; Gutierrez-Vargas, Santiago; Perez-Moreno, Luis; Ordonez- Acevedo, Leandro G.; Report Jan 1, 2017 4734
Metabolic Disorders in HIV-infected Adolescents Receiving Protease Inhibitors. Santiprabhob, Jeerunda; Tanchaweng, Surapong; Maturapat, Sirinoot; Maleesatharn, Alan; Lermankul, Wa Report Jan 1, 2017 13049
Plant Proteinase Inhibitor BbCI Modulates Lung Inflammatory Responses and Mechanic and Remodeling Alterations Induced by Elastase in Mice. Almeida-Reis, Rafael; Theodoro, Osmar A., Jr.; Oliveira, Bruno T.M.; Oliva, Leandro V.; Toledo-Arrud Report Jan 1, 2017 8589
Resistance to direct antiviral agents for hepatitis C virus infection. Impact on clinical practice? Perez, Ana Belen; Garcia, Federico Dec 1, 2016 800
AbbVie receives breakthrough therapy designation from US FDA to treat patients with hepatitis C virus infection. Oct 4, 2016 217
AbbVie receives breakthrough therapy designation from US FDA to treat patients with hepatitis C virus infection. Oct 4, 2016 213
AbbVie reports US FDA breakthrough therapy designation for investigational HCV regimen. Oct 3, 2016 233
Merck receives European Commission approval for Zepatier hepatitis C drug. Aug 2, 2016 143
Merck receives European Commission approval for Zepatier hepatitis C drug. Aug 2, 2016 139
Merck & Co awarded European Commission approval for marketing ZEPATIER for chronic hepatitis C virus (HCV). Aug 1, 2016 307
Merck & Co awarded European Commission approval for marketing ZEPATIER for chronic hepatitis C virus (HCV). Aug 1, 2016 303
Long term effect of switching to darunavir/ritonavir in HIV infected patients previously on protease inhibitor therapy. Ucciferri, Claudio; Falasca, Katia; Vignale, Francesca; Nicola, Marta Di; Vecchiet, Jacopo Report Jul 1, 2016 889
Protease inhibitors and azolic antifungals in HIV patients with histoplasmosis: a clinical pharmacokinetics perspective. Okumura, Lucas Miyake Letter to the editor Jul 1, 2016 441
Predictors of early treatment discontinuation and severe anemia in a Brazilian cohort of hepatitis C patients treated with first-generation protease inhibitors. Miotto, N.; Mendes, L.C.; Zanaga, L.P.; Goncales, E.S.L.; Lazarini, M.S.K.; Pedro, M.N.; Goncales, F Report Jul 1, 2016 6930
Low bone mineral density and associated risk factors in HIV-infected patients. Chipu-Tisu, Cristina-Emilia; Barbu, Ecaterina-Constanta; Lazar, Mihai; Ion, Daniela Adriana; Badarau Clinical report Jun 1, 2016 6091
Cambio de la terapia antiretroviral de gran actividad asociada a reacciones adversas medicamentosas en un centro especializado en Venezuela. Subiela H., Jose D.; Dapena B., Elida Mar 1, 2016 5212
Emerging roles of SPINK1 in cancer. Rasanen, Kati; Itkonen, Outi; Koistinen, Hannu; Stenman, Ulf-Hakan Report Mar 1, 2016 7337
Merck's ZEPATIER approved for HCV. Mar 1, 2016 184
Preferential inhibition of bacterial elastase over human neutrophil elastase by leaf extracts of Psidium guajava: an in vitro study. Mendez, Deena; Kutty, A.V. Moideen; Prasad, S.R. Report Mar 1, 2016 3000
Jared Cumming, Merck, to Give a Presentation at GTCbio's Protease Inhibitors Conference. Conference news Feb 19, 2016 590
Jared Cumming, Merck, to Give a Presentation at GTCbio's Protease Inhibitors Conference. Conference news Feb 11, 2016 590
Merck passes US FDA's priority review approval of ZEPATIER (elbasvir and grazoprevir) for treating Chronic Hepatitis C Virus Genotype 1 or 4 Infection. Jan 29, 2016 313
Merck passes US FDA's priority review approval of ZEPATIER (elbasvir and grazoprevir) for treating Chronic Hepatitis C Virus Genotype 1 or 4 Infection. Jan 29, 2016 317
AbbVie's data from the SURVEYOR studies of its investigational HCV regimen, ABT-493, an NS3/4A protease inhibitor, and ABT-530, an NS5A inhibitor, show high rates of sustained virologie response at 12 weeks post-treatment (SVR) in non-cirrhotic patients with chronic hepatitis C virus (HCV) infection. Jan 1, 2016 125
Tumor suppressor maspin as a modulator of host immune response to cancer. Dzinic, Sijana H.; Bernardo, M. Margarida; Oliveira, Daniel S.M.; Wahba, Marian; Sakr, Wael; Sheng, Nov 1, 2015 4098
Bone density risk factors in people with HIV: a long, familiar list. Mascolini, Mark Sep 22, 2015 4528
Bisphosphonates for bone--and advice on ARVs, calcium, vitamin D, glitazones. Mascolini, Mark Report Sep 22, 2015 2821
Protease inhibitor combinations work best with at least 95% on-time pill taking. Sep 1, 2015 1760
TAMIZAJE VIRTUAL DE COMPUESTOS INHIBIDORES DE LA SAP-2 DE CANDIDA ALBICANS. Rebollo, Juan; Reyes, Niradiz; Suarez, Paola Jul 1, 2015 2414
Report Published: "ARK Diagnostics, Inc. - Product Pipeline Analysis, 2015 Update". May 5, 2015 402
Outcomes in treatment with darunavir/ritonavir in ART-experienced paediatric patients. Kindra, Gurpreet; Sipambo, Nosisa; Moultrie, Harry; Fairlie, Lee Letter to the editor May 1, 2015 1484
Bristol-Myers' Evotaz fights HIV infection. Feb 16, 2015 148
Bristol-Myers Squibb Company passes US FDA's approval for Evotaz tablets in combination with antiretroviral agents for HIV-1 infection in adults. Feb 2, 2015 230
Bristol-Myers Squibb Company passes US FDA's approval for Evotaz tablets in combination with antiretroviral agents for HIV-1 infection in adults. Feb 2, 2015 226
Prisoners treated for hepatitis C with protease inhibitor, New York, USA, 2012. Moorjani, Harish; Koenigsmann, Carl; Kim, Min Jung; Spaulding, Anne C. Letter to the editor Jan 1, 2015 1327
Antiretroviral therapy for the management of HIV in children. Frigati, L.; Cotton, M.F.; Rabie, H. Report Dec 1, 2014 4555
Detecting virological failure in HIV-infected Tanzanian children. Mgelea, E.M.; Kisenge, R.; Aboud, S. Report Oct 1, 2014 3013
Caracterizacion del fracaso terapeutico en pacientes VIH positivos en la region del Caribe Colombiano. de la Hoz, Juan Manuel; Bolano, Laura; Cardenas, Oriana; Gonzalez, Robertulio; Sabbag, Jose; Palacio Oct 1, 2014 4264
Classic and HIV-specific risk factors for kidney disease. Mascolini, Mark Report Sep 22, 2014 6379
DAAs for HCV/HIV coinfection: lots more to learn. Mascolini, Mark Jun 22, 2014 4169
Enanta and AbbVie submits MAA to EMA for all-oral, interferon-free Hepatitis C regimen containing ABT-450. May 8, 2014 216
Enanta and AbbVie submits MAA to EMA for all-oral, interferon-free Hepatitis C regimen containing ABT-450. May 8, 2014 212
Bristol-Myers Squibb submits New Drug Application to U.S. FDA for a fixed-dose combination tablet of Atazanavir Sulfate with Cobicistat for HIV-1 patients. Apr 15, 2014 210
Bristol-Myers Squibb submits New Drug Application to U.S. FDA for a fixed-dose combination tablet of Atazanavir Sulfate with Cobicistat for HIV-1 patients. Apr 15, 2014 206
Medivir's Simeprevir approved for treatment in Russia. Mar 24, 2014 281
Medivir's Simeprevir approved for treatment in Russia. Mar 24, 2014 282
Medivir's Simeprevir approved for treatment in Russia. Mar 24, 2014 277
Telaprevir label changes include switch to twice-daily dosing. Mechcatie, Elizabeth Feb 15, 2014 290
Diabetes mellitus in HIV-infected patients receiving antiretroviral therapy. Moyo, D.; Tanthuma, G.; Mushisha, O.; Kwadiba, G.; Chikuse, F.; Cary, M.S.; Steenhoff, A.P.; Reid, M Report Jan 1, 2014 2700
Studies of inhibitory mechanisms of propeptide-like cysteine protease inhibitors. Nga, Bui T.T.; Takeshita, Yuki; Yamamoto, Misa; Yamamoto, Yoshimi Report Jan 1, 2014 5650
Once-daily protease inhibitor approved for hepatitis C. Mechcatie, Elizabeth Dec 1, 2013 535
Medivir receives approval for simeprevir 150mg capsules from US FDA's Antiviral Drugs Advisory Committee. Oct 28, 2013 162
Medivir receives approval for simeprevir 150mg capsules from US FDA's Antiviral Drugs Advisory Committee. Oct 28, 2013 166
Merck announces receipt of Breakthrough Therapy designation for MK-5172/MK-8742 for the treatment of Chronic Hepatitis C Virus (HCV) infection. Oct 23, 2013 222
HCV triple-therapy response rate is 33% in real world. Otto, M. Alexander Oct 15, 2013 413
Real-world response rate is 33% for hep C triple tx. Otto, M. Alexander Report Oct 15, 2013 394
Chymotrypsin-like protease activity in the stratum corneum is increased in atopic dermatitis and upon washing with soap. Danby, S.; Cork, M.J.; Chittock, J.; Martin, K.M.; Tierney, N.K. Oct 1, 2013 1055
Gilead Sciences Inc to offer HIV patients relying on protease inhibitors in Europe with once-daily Tybost upon approval. Sep 26, 2013 211
Gilead Sciences Inc to offer HIV patients relying on protease inhibitors in Europe with once-daily Tybost upon approval. Sep 26, 2013 207
Antiretroviral therapy: from heart risk factor to heart protector? Mascolini, Mark Jun 22, 2013 9429
Merck signs agreement with Bristol-Myers Squibb to conduct a Phase II clinical trial evaluating combination of investigational oral candidates MK-5172 and daclatasvir. Apr 23, 2013 231
Merck signs agreement with Bristol-Myers Squibb to conduct a Phase II clinical trial evaluating combination of investigational oral candidates MK-5172 and daclatasvir. Apr 23, 2013 227
Janssen seeks FDA drug application for simeprevir. Apr 1, 2013 177
Janssen seeks FDA drug application for simeprevir. Apr 1, 2013 173
Longer HIV treatment linked to lower AIDS cancer rate but has differing effects on non-AIDS cancers. Mar 1, 2013 1428
Triple therapy has poor safety in cirrhotic hep C. Osterweil, Neil Mar 1, 2013 854
The development of models based on linear and nonlinear multivariate methods to predict ADME/PK properties using physicochemical properties of kinase, protease inhibitors, and GPCR antagonists. Bakasta, Deepu; Shambhu, M.G. Report Jan 1, 2013 2900
Cutis verticis gyrata in men affected by HIV-related lipodystrophy. Khanijow, Keshav; Unemori, Patrick; Leslie, Kieron S.; Mulligan, Kathleen; Schambelan, Morris; Maure Jan 1, 2013 1661
Alpha 1-antichymotrypsin, an inflammatory protein overexpressed in the brains of patients with Alzheimer's disease, induces tau hyperphosphorylation through c-Jun n-terminal kinase activation. Tyagi, Ethika; Fiorelli, Tina; Norden, Michelle; Padmanabhan, Jaya Report Jan 1, 2013 6214
ANTIBACTERIAL ACTIVITY OF A TRYPSIN-CHYMOTRYPSIN-ELASTASE INHIBITOR ISOLATED FROM LAVATERA CASHMERIANA CAMB. SEEDS. Dec 31, 2012 2241
Safety of nevirapine in HIV-infected pregnant women initiating antiretroviral therapy at higher CD4 counts: A systematic review and meta-analysis. Bera, Ebrahim; Mia, Rafiq Report Nov 1, 2012 4701
Effects of replacement of fish meal by soy protein isolate on the growth, digestive enzyme activity and serum biochemical parameters for juvenile Amur sturgeon (Acipenser schrenckii). Xu, Q.Y.; Wang, C.A.; Zhao, Z.G.; Luo, L. Report Nov 1, 2012 5543
Hep C Rx doesn't mix well with others. Sep 15, 2012 162
Protease inhibitors and stomach acid drugs linked to fractures in HIV+ veterans. Sep 1, 2012 1443
Guidelines for antiretroviral therapy in adults. Meintjes, Graeme; Maartens, Gary; Boulle, Andrew; Conradie, Francesca; Goemaere, Eric; Hefer, Eric; Report Sep 1, 2012 17556
Drug-drug interactions added to hepatitis C drug label. Mechcatie, Elizabeth Aug 1, 2012 365
Purification of a membrane-bound trypsin-like enzyme from the gut of the velvetbean caterpillar (Anticarsia gemmatalis Hubner)/Purificacao de uma enzima "tipo tripsina" nao-soluvel do intestino da lagarta da soja (Anticarsia gemmatalis Hubner). Reis, Denise Torres Cruz; dos Mares-Guia, Thiago Renno; de Oliveira, Jamil Silvano; Santos, Alexandr Jul 1, 2012 4359
Gilead Sciences Inc submits NDA to US FDA to market boosting agent, cobicistat. Jun 29, 2012 165
Seminal plasma components and its influence on cryopreservation and fertility of equine spermatozoa/Componentes do plasma seminal e sua influencia sobre a criopreservacao e fertilidade de espermatozoides equinos/Componentes del plasma seminal y su influencia sobre las criopreservacion y fertilidad de espermatozoides equinos. Guasti, Priscilla Nascimento; Monteiro, Gabriel Augusto; Papa, Frederico Ozanam Jun 1, 2012 4548
Calpastatin (CAST) Gene Polymorphism and its Association with Average Daily Weight Gain in Balkhi and Kajli Sheep and Beetal Goat Breeds. Khan, Saeed-ul-Hassan; Riaz, Muhammad Naeem; Ghaffar, Abdul; Khan, Muhammad Fatah Ullah Report Apr 30, 2012 3437
Some prescription drugs inhibit 17P metabolism. Worcester, Sharon Apr 1, 2012 772
Achillion's protease inhibitor gets FDA Fast Track designation for chronic hepatitis C. Jan 4, 2012 148
-Medivir's partner Tibotec, US Bristol-Myers to study hepatitis C drug. Dec 2, 2011 227
-Medivir's partner Tibotec, US Bristol-Myers to study hepatitis C drug. Dec 2, 2011 229
Tissue factor pathway inhibitor in paediatric patients with nephrotic syndrome. Farid, Farida Ahmed; Mohammed, Ahmed Abdullah; Beltagi, Rania Saleh; Afify, Hanaa Mohammed Report Dec 1, 2011 3344
HIV testing update. Cohen, Jenny K.; Klausner, Jeffrey D. Report Nov 1, 2011 5418
SPINK1: a new therapeutic target in cancer? Stenman, Ulf-Hakan Nov 1, 2011 1572
ViiV Healthcare begins Phase III HIV study of Celsentri/Selzentry versus Truvada, in combination with protease inhibitor. Oct 12, 2011 192
Pharmacokinetic interactions between antiretrovirals and rifampicin-based tuberculosis treatment. Cohen, Karen Oct 1, 2011 801
HEALTH SECTOR -Turkish cure to Hepatitis C and AIDS. Jul 1, 2011 295
FDA okays antiviral telaprevir for hepatitis C treatment. Mechcatie, Elizabeth Jun 15, 2011 439
FDA approves second hep C agent. Jun 1, 2011 182
MSD announces positive opinion by CHMP for VICTRELIS as oral Hepatitis C Virus (HCV) protease inhibitor. May 23, 2011 314
Medivir shares interim data from TMC435 hepatitis C Phase IIb ASPIRE study. Clinical report May 20, 2011 259
Protease inhibitors poised to improve HCV outcomes. Mechcatie, Elizabeth May 15, 2011 554
Adverse effects of ARV use in pregnancy: prematurity continues to raise concerns. Report May 1, 2011 847
Prevalence and factors associated with darunavir resistance mutations in multi-experienced HIV-1-infected patients failing other protease inhibitors in a referral teaching center in Brazil. Vidal, Jose E.; Freitas, Angela C.; Song, Alice T.W.; Campos, Silvia V.; Dalben, Mirian; Hernandez, May 1, 2011 2258
FDA committee recommends approval of Merck's VICTRELIS in HCV genotype 1 infection. Apr 28, 2011 186
Mercka[euro](tm)s VICTRELIS unanimously recommended for approval by FDA advisory committee for treatment of chronic HCV Genotype 1 Infection. Apr 28, 2011 240
Agent improves sustained virologic response in HCV-1. Moon, Mary Ann Apr 15, 2011 912
Boehringer Ingelheim presents results with investigational HCV protease inhibitor. Apr 4, 2011 218
High rate of bone thinning in people with long antiretroviral treatment. Mar 1, 2011 1714
Older age when starting antiretrovirals lowers chance of good CD4 gain. Mar 1, 2011 1673
Virologic response rates exceed 80% with telaprevir Combo. Moon, Mary Ann Feb 1, 2011 750
An antifungal defensin from Phaseolus vulgaris cv. 'cloud bean'. Wu, Xiangli; Sun, Jian; Zhang, Guoqing; Wang, Hexiang; Ng, Tzi Bun Report Jan 15, 2011 4563
Teaching pill swallowing to HIV-infected children. Krechevsky, Dean; Melvin, Diane; Head, Stephen Report Dec 22, 2010 2353
The effect of feeding different levels of sardine fish silage on broiler performance, meat quality and sensory characteristics under closed and open-sided housing systems. Marzooqi, W. Al-; Farsi, M.A. Al-; Kadim, I.T.; Mahgoub, O.; Goddard, J.S. Report Nov 30, 2010 9617
Irreversible inhibition of a protease central to hepatitis C infection: Study. Nov 29, 2010 306
Phase III: telaprevir, boceprevir boost response rates to standard chronic hepatitis C treatment. Mahoney, Diana Report Nov 15, 2010 1435
Tibotec announces positive interim results from Phase IIb study of TMC435 in hepatitis C. Nov 1, 2010 278
One third on first-line antiretrovirals have serious drug interaction. Nov 1, 2010 1250
Boehringer Ingelheim Oral Hepatitis C Protease Inhibitor and Polymerase Inhibitor Combination Shows Rapid Viral Response without Use of Pegylated Interferon. Oct 31, 2010 421
Identification and evaluation of trypsin inhibitor in the seed extracts of Butea Monosperma (flame of forest). Pandey, Prabhash K.; Jamal, Farrukh Oct 1, 2010 2344
A rare phenomenon of atypical lipodystrophy in a patient on HAART in the absence of a protease inhibitor regimen. Mitha, Mohammed; Cupido, Gordon; Taljaard, Jantjie Case study Sep 1, 2010 920
A dimeric high-molecular-weight chymotrypsin inhibitor with antitumor and HIV-1 reverse transcriptase inhibitory activities from seeds of Acacia confusa. Lam, S.K.; Ng, T.B. Report Jul 1, 2010 3781
A review of paediatric HIV in the UK and Ireland. Goode, Michele; Butler, Karina Jun 22, 2010 3167
New hope for hepatitis C sufferers. Apr 11, 2010 283
More new non-AIDS illnesses with Epzicom than Truvada in 96-week trial. Apr 1, 2010 1768
Effects of processing methods on the protein quality of mucuna bean (Mucuna pruriens L.). Mugendi, J.B.; Njagi E.N.M.; Kuria, E.N.; Mwasaru, M.A.; Mureithi, J.G.; Apostolides, Z. Report Apr 1, 2010 5839
A review of the use of activation markers in Africa. John, Laurence; Lutwama, Fred Report Mar 1, 2010 4036
The impact of the Ryan White Treatment Modernization Act on social work within the field of HIV/AIDS service provision. Rowan, Diana M.; Honeycutt, Joey Report Feb 1, 2010 2426
Regional and temporal trends in migration among people living with HIV/AIDS in British Columbia, 1993-2005. Lima, Viviane D.; Druyts, Eric; Montaner, Julio S.G.; Hogg, Robert S. Report Jan 1, 2010 3479
Delayed deproteinization causes methodological errors in amino acid levels in plasma stored at room temperature or -20[degrees]C. Li, Junyou; Piao, Chunxiang; Jin, Huazi; Wongpanit, Kannika; Manabe, Noboru Report Dec 1, 2009 4096
Immune activation and the pathogenesis of HIV disease: implications for therapy. Fernandez, Sonia; Lim, Andrew; French, Martyn Report Nov 1, 2009 4580
HIV, atherosclerosis and inflammation: implications for treatment. Chan, William; Sviridov, Dmitri; Dart, Anthony M. Report Nov 1, 2009 6415
Response and resistance with Prezista versus Kaletra after earlier treatment. Oct 1, 2009 1036
Prezista and Isentress can get into nervous system and brain to attack HIV. Oct 1, 2009 1167
Ten thoughts on how HIV care may change in 10 years. Mascolini, Mark Sep 22, 2009 15186
Missing protein in rare genetic brain disorder restored. Sep 7, 2009 445
Here's how Hepatitis C treatment can be significantly improved. Jun 6, 2009 424
A protein with antiproliferative, antifungal and HIV-1 reverse transcriptase inhibitory activities from caper (Capparis spinosa) seeds. Lam, Sze-Kwan; Ng, Tzi-Bun Report May 1, 2009 3897
A Schering-Plough Corp (Kenilworth NJ) drug knocked the hepatitis C virus down to undetectable levels in three-fourths of patients in a mid-stage study, twice the effectiveness seen with standard treatments, researchers said. Brief article Apr 27, 2009 304
Vertex Pharmaceutical Inc's (Cambridge MA) experimental hepatitis C drug telaprevir wiped out signs of the infection in half of patients with hard-to-treat forms of the disease in a yearlong study. Brief article Apr 27, 2009 242
Pfizer stops cancer trial after strong results: Eurand gets orphan designation for EUR-1073. Apr 1, 2009 1655
New antiretrovirals: what's in it for Southern Africa? Venter, W.D. Francois; Osih, Regina; Andrews, Steve; Conradie, Francesca Mar 22, 2009 3704
Switching from kalestra to Isentress poses risk of viral rebound. Mar 1, 2009 871
Therapy approach associate with carnitine supplementation and physical exercise in the HIV lipodystrophic syndrome/Abordagem terapeutica associada a suplementacao de carnitina e exercicios fisicos na sindrome lipodistrofica do HIV. Guerra, Vera Lucia Afonso; Navarro, Francisco Nov 1, 2008 6788
Rhabdomyolysis: a case study exploring the possible side effect of lipid lowering medication by a HIV positive patient taking a protease inhibitor. De Carvalho, Diana; Citro, Mark; Tibbles, Anthony Case study Oct 1, 2008 2822
New protease inhibitors and non-nucleoside reverse transcriptase inhibitors. Lascar, Monica; Cartledge, Jonathan D. Drug overview Jun 1, 2008 3759
The current role of ritonavir-boosted protease inhibitors in the management of HIV infection. Wilkins, Ed Report Mar 1, 2008 7693
Updated information regarding antiretroviral agents used as HIV postexposure prophylaxis for occupational HIV exposures. Dec 14, 2007 711
Novel neutrophil-derived proteins in bronchoalveolar lavage fluid indicate an exaggerated inflammatory response in pediatric cystic fibrosis patients. McMorran, Brendan J.; Patat, Severine A. Ouvry; Carlin, John B.; Grimwood, Keith; Jones, Alun; Armst Report Oct 1, 2007 6027
Chronic wounds, molecular pathogenesis and active therapies. Trotter, Patrick Sep 1, 2007 3535
Hybridization probe genotyping of the R67X nonsense polymorphism in the protein z-dependent protease inhibitor reveals a new R67Q mutation. Burggraf, Siegfried; Dorhofer, Barbara; Olgemoller, Bernhard Letter to the editor Jul 1, 2007 973
Efficacy and safety of darunavir-ritonovir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: a pooled subgroup analysis of data from two randomised trials. Chan, Derek J. Jun 1, 2007 416
Non-nucleoside reverse transcriptase inhibitor (NNRTI) HIV treatment regimens are better at suppressing the virus than protease inhibitor (PI) regimens. Brief article Jan 1, 2007 148
FDA approves sitagliptin for glycemic control. Tucker, Miriam E. Nov 1, 2006 714
Protease inhibitor-associated dyslipidemia in HIV-infected patients is strongly influenced by the APOA5-1131T [right arrow] C gene variation. Guardiola, Montse; Ferre, Raimon; Salazar, Juliana; Alonso-Villaverde, Carlos; Coll, Blai; Parra, Sa Oct 1, 2006 3598
Methodologic European external quality assurance for DNA sequencing: the EQUALseq program. Ahmad-Nejad, Parviz; Dorn-Beineke, Alexandra; Pfeiffer, Ulrike; Brade, Joachim; Geilenkeuser, Wolf-J Report Apr 1, 2006 6839
Have Meds, Will Travel Traveling with meds has always been a challenge for HIVers, but things got a bit easier in October when the FDA approved a tablet form of the protease inhibitor Kaletra, making one of the world's most commonly prescribed protease inhibitors travel-ready. Brief Article Jan 17, 2006 97
Application of proteomic technology in identifying pancreatic secretory trypsin inhibitor variants in urine of patients with pancreatitis. Valmu, Leena; Paju, Annukka; Lempinen, Marko; Kemppainen, Esko; Stenman, Ulf-Hakan Jan 1, 2006 5406
Novel protease inhibitor has strong antiviral activity. Laino, Charlene Oct 15, 2005 437
Treatments coming for resistant hepatitis C. Kirn, Timothy F. Aug 1, 2005 678
HIV protease inhibitors vs. malaria. James, John S. Brief Article Jun 24, 2005 122
Tipranavir (Aptivus): approval cautiously recommended. James, John S. May 27, 2005 1145
Drug changes may reverse lipoatrophy in HIV: researchers will consider new combinations of drugs that may have favorable effects on fat distribution. Mahoney, Diana May 1, 2005 982
Good news: the effects of HAART. Brief Article Apr 1, 2005 185
TMC 114. Brief Article Apr 1, 2005 84
Tipranavir. Apr 1, 2005 91
Erythromycin risks. Brief Article Apr 1, 2005 198
Drugs for GI upset may interact with HIV protease inhibitors. Brief Article Apr 1, 2005 214
Kaletra warning. Advertisement Apr 1, 2005 296
New protease inhibitor looks promising. Brief Article Mar 26, 2005 145
HIV/AIDS; Treatment. Mar 16, 2005 1732
New protease inhibitor may held when others fail. Zoler, Mitchel L. Feb 1, 2005 688
New protease inhibitor controls HIV when other agents fail. Zoler, Mitchel L. Dec 1, 2004 663
Triple PI therapy for salvage. Brief Article Oct 1, 2004 165
Reyataz update. Brief Article Oct 1, 2004 153
The hepatitis C drug development pipeline. Raymond, Daniel Sep 22, 2004 2442
Development of sensitive immunoassays for free and total human glandular kallikrein 2. Vaisanen, Ville; Eriksson, Susann; Ivaska, Kaisa K.; Lilja, Hans; Nurmi, Martti; Pettersson, Kim Report Sep 1, 2004 8059
FDA approves HIV drug. Brief Article Jun 1, 2004 114
New protease inhibitor being studied. Brief Article Jun 1, 2004 132
Pravastatin of some help in short trial: tough to curb PI-induced hyperlipidemia in HIV. Boschert, Sherry Apr 1, 2004 551
Statin model helps negate hyperlipidemia in HIV: culprit: protease inhibitors. Boschert, Sherry Apr 1, 2004 536
Watch for 'bumper crop' of HIV drugs. Finn, Robert Mar 15, 2004 707
Promising new HIV drugs expected within next 2-5 years: amdoxovir, SPD-754, tipranavir. Finn, Robert Feb 15, 2004 706
Revised guidelines simplify HIV/AIDS regimens; 'preferred' and 'alternative' regimens. Finn, Robert Feb 1, 2004 566
Drug disables enzyme from hepatitis C virus. Travis, J Nov 1, 2003 456
Lexiva[TM] (Fosamprenavir) approved. Brief Article Oct 31, 2003 197
Protease inhibitors and Viagra. Brief Article Sep 15, 2003 187
Several agents under study for hepatitis C virus. (Oral Protease Inhibitor, Vaccine). Norton, Patrice G.W. Jul 1, 2003 554
Frequency, risk factors, and outcome of hyperlactatemia in HIV-positive persons: implications for the management of treated patients. Marceau, Geoffroy; Sapin, Vincent; Jacomet, Christine; Ughetto, Sylvie; Cormerais, Louis; Regagnon, Clinical report Jul 1, 2003 5805
New protease inhibitor atazanavir (Reyataz[TM]) approved. Jun 27, 2003 436
Viagra and protease inhibitors. (Clinical Capsules). Brief Article Jun 15, 2003 154
Atazanavir background documents available. Brief Article May 30, 2003 193
Atazanavir expanded access. (Treatment News). Brief Article May 1, 2003 93
Purification of human kallikrein 6 from biological fluids and identification of its complex with [[alpha].sub.1]-antichymotrypsin. Hutchinson, Shirley; Luo, Liu-Ying; Yousef, George M.; Soosaipillai, Antoninus; Diamandis, Eleftheri May 1, 2003 3813
Protease inhibitors up sildenafil. (Use Lower Dose). Finn, Robert Brief Article Mar 15, 2003 187
Use of protease inhibitors raises MI risk sevenfold. (Don't Curtail Prescribing). Zoler, Mitchel L. Brief Article Mar 1, 2003 297
Success of experimental AIDS drugs offers promise of future therapies. (Full pipeline). Seppa, N. Feb 22, 2003 512
Protease inhibitors and MI risk. (Clinical Capsules). Worcester, Sharon Brief Article Feb 1, 2003 220
New Cafergot contraindication. (Clinical Capsules). Brief Article Feb 1, 2003 122
HIV therapies may carry health risks. Zipes, Douglas Feb 1, 2003 320
Human kallikrein 13: production and purification of recombinant protein and monoclonal and polyclonal antibodies, and development of a sensitive and specific immunofluorometric assay. Kapadia, Carl; Chang, Albert; Sotiropoulou, Georgia; Yousef, George M.; Grass, Linda; Soosaipillai, Jan 1, 2003 5939
Human kallikrein 8: immunoassay development and identification in tissue extracts and biological fluids. Kishi, Tadaaki; Grass, Linda; Soosaipillai, Antoninus; Shimizu-Okabe, Chigusa; Diamandis, Eleftherio Jan 1, 2003 5726
Protease inhibitor combination sustains virologic response. (No Resistance After 4 Years). Boschert, Sherry Product/Service Evaluation Dec 1, 2002 390
Another cardiovascular risk with protease inhibitors? (Treatment News). Brief Article Sep 1, 2002 190
The proportion of prostate-specific antigen (PSA) complexed to [[alpha].sub.1]-antichymotrypsin improves the discrimination between prostate cancer and benign prostatic hyperplasia in men with a total PSA of 10 to 30 [micro]g/L. Martinez, Manuel; Espana, Francisco; Royo, Montserrat; Alapont, Jose M.; Navarro, Silvia; Estelles, Clinical report Aug 1, 2002 4555
New protease inhibitor easy on lipids, tackles resistance. (Doesn't Raise Lipid Levels). Kirn, Timothy F. Brief Article May 1, 2002 398
Early coronary heart disease strikes protease inhibitor users. (Identify, Treat Risk Factors). Jancin, Bruce Brief Article Apr 1, 2002 282

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters